These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17912457)
1. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Deissler H; Kuhn EM; Lang GE; Deissler H Int J Mol Med; 2007 Nov; 20(5):643-52. PubMed ID: 17912457 [TBL] [Abstract][Full Text] [Related]
2. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells. Deissler HL; Lang GK; Lang GE Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334 [TBL] [Abstract][Full Text] [Related]
3. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin. Cook GA; Wilkinson DA; Crossno JT; Raghow R; Jennings LK Exp Cell Res; 1999 Sep; 251(2):356-71. PubMed ID: 10471321 [TBL] [Abstract][Full Text] [Related]
4. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280 [TBL] [Abstract][Full Text] [Related]
5. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: Impact on tumor cell motility. Rana S; Claas C; Kretz CC; Nazarenko I; Zoeller M Int J Biochem Cell Biol; 2011 Jan; 43(1):106-19. PubMed ID: 20937409 [TBL] [Abstract][Full Text] [Related]
6. Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway. Kotha J; Longhurst C; Appling W; Jennings LK Exp Cell Res; 2008 May; 314(8):1811-22. PubMed ID: 18358474 [TBL] [Abstract][Full Text] [Related]
7. VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells. Deissler H; Deissler H; Lang S; Lang GE Br J Ophthalmol; 2008 Jun; 92(6):839-43. PubMed ID: 18511543 [TBL] [Abstract][Full Text] [Related]
8. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. Ishii M; Iwai K; Koike M; Ohshima S; Kudo-Tanaka E; Ishii T; Mima T; Katada Y; Miyatake K; Uchiyama Y; Saeki Y J Bone Miner Res; 2006 Jun; 21(6):965-76. PubMed ID: 16753027 [TBL] [Abstract][Full Text] [Related]
9. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells. Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373 [TBL] [Abstract][Full Text] [Related]
10. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. Castro-Sanchez L; Soto-Guzman A; Navarro-Tito N; Martinez-Orozco R; Salazar EP Eur J Cell Biol; 2010 Nov; 89(11):843-52. PubMed ID: 20709424 [TBL] [Abstract][Full Text] [Related]
11. Palmitoylation supports the association of tetraspanin CD63 with CD9 and integrin alphaIIbbeta3 in activated platelets. Israels SJ; McMillan-Ward EM Thromb Res; 2010 Feb; 125(2):152-8. PubMed ID: 19640571 [TBL] [Abstract][Full Text] [Related]
12. CD9 expression on lymphatic vessels in head and neck mucosa. Erovic BM; Neuchrist C; Kandutsch S; Woegerbauer M; Pammer J Mod Pathol; 2003 Oct; 16(10):1028-34. PubMed ID: 14559986 [TBL] [Abstract][Full Text] [Related]
13. alpha2beta1 integrin controls association of Rac with the membrane and triggers quiescence of endothelial cells. Cailleteau L; Estrach S; Thyss R; Boyer L; Doye A; Domange B; Johnsson N; Rubinstein E; Boucheix C; Ebrahimian T; Silvestre JS; Lemichez E; Meneguzzi G; Mettouchi A J Cell Sci; 2010 Jul; 123(Pt 14):2491-501. PubMed ID: 20592186 [TBL] [Abstract][Full Text] [Related]
14. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients. De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214 [TBL] [Abstract][Full Text] [Related]
15. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer. Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of murine retinal endothelial cells. Su X; Sorenson CM; Sheibani N Mol Vis; 2003 May; 9():171-8. PubMed ID: 12740568 [TBL] [Abstract][Full Text] [Related]
17. CD9 participates in endothelial cell migration during in vitro wound repair. Klein-Soyer C; Azorsa DO; Cazenave JP; Lanza F Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):360-9. PubMed ID: 10669631 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
19. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Kamisasanuki T; Tokushige S; Terasaki H; Khai NC; Wang Y; Sakamoto T; Kosai K Biochem Biophys Res Commun; 2011 Sep; 413(1):128-35. PubMed ID: 21875571 [TBL] [Abstract][Full Text] [Related]
20. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]